Verstovsek S, Foltz L, Gupta V, Hasserjian R, et al. Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial. Haematologica 2023;108:2730-2742.
PMID: 37165840